Evotec Tech Sells Single Molecule Detection Technology, IP to Olympus | GenomeWeb
NEW YORK (GenomeWeb News) — Evotec Technologies has sold the “core” of its single molecule detection technology and transferred or licensed the related IP to Olympus, the company said today.
 
The move is in line with the Evotec division’s goal of focusing its business more on cell imaging and cell handling systems, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.